Searching for new mechanisms of myocardial fibrosis with diagnostic and/or therapeutic potential.
about
The role of titin and extracellular matrix remodelling in heart failure with preserved ejection fractionMyocardial fibrosis: biomedical research from bench to bedside.Current Understanding of the Pathophysiology of Myocardial Fibrosis and Its Quantitative Assessment in Heart Failure.EFFECT OF TRIPTOLIDE ON PROLIFERATION AND APOPTOSIS OF ANGIOTENSIN II-INDUCED CARDIAC FIBROBLASTS IN VITRO: A PRELIMINARY STUDYThe Soft- and Hard-Heartedness of Cardiac Fibroblasts: Mechanotransduction Signaling Pathways in Fibrosis of the Heart.Preventive and chronic mineralocorticoid receptor antagonism is highly beneficial in obese SHHF rats.Aging and the cardiac collagen matrix: Novel mediators of fibrotic remodellingA Clinical Perspective of Anti-Fibrotic Therapies for Cardiovascular Disease.Metabolic support for the heart: complementary therapy for heart failure?Noncoding RNAs in Heart Failure.TRPC3 Channels in Cardiac Fibrosis.Rationale of the FIBROTARGETS study designed to identify novel biomarkers of myocardial fibrosis.Cohort Profile: Rationale and design of the fourth visit of the STANISLAS Cohort: a familial longitudinal population-based cohort from the Nancy region of France.Publishing in a heart failure journal-where lies the scientific interest?Cardiac Fibrosis: The Beneficial Effects of Exercise in Cardiac Fibrosis.Cardiac extracellular matrix is associated with adverse outcome in patients with chronic heart failure.Therapeutic Potential of Polyphenols in Cardiac Fibrosis.Liver fibrosis score predicts mortality in heart failure patients with preserved ejection fraction.
P2860
Q26765101-9C1458C7-A4EC-495F-AA3D-1F6D763C089FQ30362840-3C9E8C01-7AEF-4056-ADCC-E939DC399967Q33595504-4CC32DD2-0BA6-4FDD-B3A6-D98D83A2ABB7Q33622959-E8EC4E66-F223-47DA-B3F5-619DB2484581Q33737254-F6ADADD3-DA28-4792-A59B-04FD1B553AEEQ36903395-BA9F7C98-801C-4903-B534-E96FDFC1D0FBQ37096257-B962CCE5-6675-4817-A874-D9D00863F265Q37739117-A7C58CA9-C474-4B0A-BA68-0AEF1E682C48Q38998576-1AAD555B-4913-4590-87DE-BABD4E4DF84CQ39044115-8880C87E-98EB-44C4-86F8-6001F5DE0429Q41313867-E65AB2C8-928E-407F-93E5-9C141D16524FQ47843525-F168493A-B5D6-4475-8AFE-2AF48D63AC8AQ50002658-7A617543-2033-4CC0-84E4-F18C32C46D22Q50048824-753BDFE1-A5FF-4726-8791-5458899F3F6EQ50096393-3C8A7950-D300-4CFA-8F2E-DEECF2617341Q52819862-178D4620-4246-4617-A033-B8428F1F1E7CQ55289622-1E600B6B-DAB7-4385-A933-55A017FC5D2BQ55413275-2568EB8E-E638-4940-B601-FA80759B64DE
P2860
Searching for new mechanisms of myocardial fibrosis with diagnostic and/or therapeutic potential.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Searching for new mechanisms o ...... and/or therapeutic potential.
@en
type
label
Searching for new mechanisms o ...... and/or therapeutic potential.
@en
prefLabel
Searching for new mechanisms o ...... and/or therapeutic potential.
@en
P2093
P2860
P50
P356
P1476
Searching for new mechanisms o ...... and/or therapeutic potential.
@en
P2093
Anna P Papageorgiou
Arantxa González
Javier Díez
Natalia López-Andrés
Stephane Heymans
Thomas Thum
P2860
P304
P356
10.1002/EJHF.312
P577
2015-06-30T00:00:00Z